scholarly journals Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women

Bone ◽  
2010 ◽  
Vol 47 (1) ◽  
pp. 83-92 ◽  
Author(s):  
Anita Undale ◽  
Bhuma Srinivasan ◽  
Matthew Drake ◽  
Louise McCready ◽  
Elizabeth Atkinson ◽  
...  
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women ◽  
Osteogenic Cells ◽  
Circulating Osteogenic Cells

Corrigendum to “Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women” [Bone 47 (2010) 83–92]

Bone ◽  
2011 ◽  
Vol 48 (3) ◽  
pp. 671
Author(s):  
Anita Undale ◽  
Bhuma Srinivasan ◽  
Matthew Drake ◽  
Louise McCready ◽  
Elizabeth Atkinson ◽  
...  
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women ◽  
Osteogenic Cells ◽  
Circulating Osteogenic Cells

Hypercholesterolemia accelerates bone loss in postmenopausal women

Climacteric ◽  
2011 ◽  
Vol 14 (1) ◽  
pp. 105-111 ◽  
Author(s):  
A. Tarakida ◽  
K. Iino ◽  
K. Abe ◽  
R. Taniguchi ◽  
T. Higuchi ◽  
...  
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women

One-year psoas training can prevent lumbar bone loss in postmenopausal women: A randomized controlled trial

1993 ◽  
Vol 53 (5) ◽  
pp. 307-311 ◽  
Author(s):  
M. Revel ◽  
M. A. Mayoux-Benhamou ◽  
J. P. Rabourdin ◽  
F. Bagheri ◽  
C. Roux
Keyword(s):  
Randomized Controlled Trial ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
One Year

The relationship of severe health disorders with bone loss, grip strength, and mobility in postmenopausal women – a 15-year follow-up study

2015 ◽  
Vol 38 (14) ◽  
pp. 1407-1414
Author(s):  
Juha Suuronen ◽  
Samu Sjöblom ◽  
Risto Honkanen ◽  
Heli Koivumaa-Honkanen ◽  
Heikki Kröger ◽  
...  
Keyword(s):  
Bone Loss ◽  
Grip Strength ◽  
Postmenopausal Women ◽  
Follow Up Study ◽  
Health Disorders ◽  
Relationship Of ◽  
The Relationship

PREDICTION OF RAPID BONE LOSS IN POSTMENOPAUSAL WOMEN

The Lancet ◽  
1987 ◽  
Vol 329 (8542) ◽  
pp. 1105-1108 ◽  
Author(s):  
C. Christiansen ◽  
B.J. Riis ◽  
P. Rødbro
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women

scholarly journals TSH suppressive therapy and bone

2020 ◽  
Vol 9 (7) ◽  
pp. R158-R172 ◽  
Author(s):  
Alessandro Brancatella ◽  
Claudio Marcocci
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women ◽  
Bone Cells ◽  
Trabecular Bone Score ◽  
Experimental Studies ◽  
Bone Architecture ◽  
Tsh Receptor ◽  
Suppressive Therapy ◽  
Mineral Density ◽  
Increased Risk

Thyroid hormones stimulate bone turnover in adults by increasing osteoclastic bone resorption. TSH suppressive therapy is usually applied in patients with differentiated thyroid cancer (DTC) to improve the disease outcome. Over the last decades several authors have closely monitored the potential harm suffered by the skeletal system. Several studies and meta-analyses have shown that chronic TSH suppressive therapy is safe in premenopausal women and men. Conversely, in postmenopausal women TSH suppressive therapy is associated with a decrease of bone mineral density, deterioration of bone architecture (quantitative CT, QCT; trabecular bone score, TBS), and, possibly, an increased risk of fractures. The TSH receptor is expressed in bone cells and the results of experimental studies in TSH receptor knockout mice and humans on whether low TSH levels, as opposed to solely high thyroid hormone levels, might contribute to bone loss in endogenous or exogenous thyrotoxicosis remain controversial. Recent guidelines on the use of TSH suppressive therapy in patients with DTC give value not only to its benefit on the outcome of the disease, but also to the risks associated with exogenous thyrotoxicosis, namely menopause, osteopenia or osteoporosis, age >60 years, and history of atrial fibrillation. Bone health (BMD and/or preferably TBS) should be evaluated in postmenopausal women under chronic TSH suppressive therapy or in those patients planning to be treated for several years. Antiresorptive therapy could also be considered in selected cases (increased risk of fracture or significant decline of BMD/TBS during therapy) to prevent bone loss.

scholarly journals The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer

2001 ◽  
Vol 84 (8) ◽  
pp. 1047-1051 ◽  
Author(s):  
T Saarto ◽  
L Vehmanen ◽  
I Elomaa ◽  
M Välimäki ◽  
P Mäkelä ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Loss ◽  
Postmenopausal Women
Sign in / Sign up

Export Citation Format

Share Document